STOCK TITAN

Restricted shares granted to Greyt Ventures in Zeo ScientifiX (ZEOX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. reported an insider equity award involving Greyt Ventures, LLC, a 10% owner. On January 14, 2026, Greyt Ventures received 175,000 shares of Zeo ScientifiX common stock as a grant of restricted shares at a stated price of $0 per share under the company’s 2021 Equity Incentive Plan.

The restricted shares vest in two equal tranches: 50% on the eighth-month anniversary of the grant date and the remaining 50% on the twelfth-month anniversary. Following this grant, Greyt Ventures indirectly beneficially owned 425,000 shares of Zeo ScientifiX common stock. The filing notes these securities were issued to Greyt Ventures, LLC, which is owned by a trust for which Ms. Wendy Grey serves as trustee.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grey Wendy

(Last) (First) (Middle)
GREYT VENTURES, LLC
20533 BISCAYNE BOULEVARD, SUITE 648

(Street)
AVENTURA FL 33180

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zeo ScientifiX, Inc. [ ZEOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/14/2026 A(1) 175,000 A $0 425,000 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Grey Wendy

(Last) (First) (Middle)
GREYT VENTURES, LLC
20533 BISCAYNE BOULEVARD, SUITE 648

(Street)
AVENTURA FL 33180

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Greyt Ventures, LLC

(Last) (First) (Middle)
20533 BISCAYNE BOULEVARD, SUITE 648

(Street)
AVENTURA FL 33180

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary.
2. Securities issued to Greyt Ventures, LLC by Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee.
/s/ Wendy Grey 01/16/2026
/s/ Wendy Grey, Manager 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zeo ScientifiX (ZEOX) disclose in this Form 4?

The filing discloses that Greyt Ventures, LLC, a 10% owner, received a grant of 175,000 restricted shares of Zeo ScientifiX common stock on January 14, 2026 at a stated price of $0 per share.

Who is Greyt Ventures, LLC in relation to Zeo ScientifiX (ZEOX)?

Greyt Ventures, LLC is reported as a 10% owner of Zeo ScientifiX, Inc. The securities were issued to Greyt Ventures, LLC, which is owned by a trust for which Ms. Wendy Grey is trustee.

How many Zeo ScientifiX shares does Greyt Ventures own after the reported transaction?

After the grant, Greyt Ventures, LLC is reported as indirectly beneficially owning 425,000 shares of Zeo ScientifiX common stock.

What are the vesting terms for the 175,000 restricted shares granted by Zeo ScientifiX?

The 175,000 restricted shares vest 50% on the eighth-month anniversary of the grant date and the remaining 50% on the twelfth-month anniversary, under the 2021 Equity Incentive Plan.

Does the Form 4 indicate who signed on behalf of the reporting persons?

Yes. The Form 4 is signed “/s/ Wendy Grey, Manager”, dated January 16, 2026, indicating Ms. Wendy Grey signed in her capacity as manager.

Is the reported Zeo ScientifiX transaction a purchase or an award of stock?

The transaction is coded as A for acquisition and described as a grant of restricted shares under the 2021 Equity Incentive Plan, rather than an open-market purchase.
ZEO ScientifiX

OTC:ZEOX

ZEOX Rankings

ZEOX Latest News

ZEOX Latest SEC Filings

ZEOX Stock Data

9.87M
3.56M
45.68%
Biotechnology
Healthcare
Link
United States
Davie